PI3K/AKT信号通路在肿瘤中的研究进展

被引:104
作者
施银
冯晓兰
谢李芬
王筱冰
机构
[1] 陕西师范大学生命科学学院
关键词
PI3K/AKT; 信号通路; 肿瘤;
D O I
10.13488/j.smhx.20180312
中图分类号
R730.2 [肿瘤病理学、病因学];
学科分类号
100214 [肿瘤学];
摘要
恶性肿瘤的发生发展是多种信号传导通路共同作用的结果。在多种肿瘤发生过程中PI3K/AKT信号传导通路出现异常活化,该通路在肿瘤发生发展过程中起着关键作用,参与肿瘤细胞存活、增殖、侵袭与迁移的调控。抑制该通路的方案已成为肿瘤治疗的研究热点。文章对PI3K/AKT通路的组成、分子机制、功能以及与肿瘤的关系进行了综述。
引用
收藏
页码:421 / 426
页数:6
相关论文
共 13 条
[1]
布洛芬通过PI3K/Akt/mTOR信号通路调控肝癌QGY-7703细胞迁移和侵袭的机制 [J].
南振华 ;
潘灵辉 .
肿瘤防治研究, 2016, 43 (12) :1035-1038
[2]
PI3K class II α regulates δ-opioid receptor export from the trans-Golgi network [J].
Shiwarski, Daniel J. ;
Darr, Marlena ;
Telmer, Cheryl A. ;
Bruchez, Marcel P. ;
Puthenveedu, Manojkumar A. .
MOLECULAR BIOLOGY OF THE CELL, 2017, 28 (16) :2202-2219
[3]
Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development [J].
Wilde, Lindsay ;
Roche, Megan ;
Domingo-Vidal, Marina ;
Tanson, Katherina ;
Philp, Nancy ;
Curry, Joseph ;
Martinez-Outschoorn, Ubaldo .
SEMINARS IN ONCOLOGY, 2017, 44 (03) :198-203
[4]
Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton [J].
Hu, Hai ;
Juvekar, Ashish ;
Lyssiotis, Costas A. ;
Lien, Evan C. ;
Albeck, John G. ;
Oh, Doogie ;
Varma, Gopal ;
Hung, Yin Pun ;
Ullas, Soumya ;
Lauring, Josh ;
Seth, Pankaj ;
Lundquist, Mark R. ;
Tolan, Dean R. ;
Grant, Aaron K. ;
Needleman, Daniel J. ;
Asara, John M. ;
Cantley, Lewis C. ;
Wulf, Gerburg M. .
CELL, 2016, 164 (03) :433-446
[5]
MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma [J].
Zhang, Yuqin ;
Zheng, Lin ;
Ding, Yi ;
Li, Qi ;
Wang, Rong ;
Liu, Tongxin ;
Sun, Quanquan ;
Yang, Hua ;
Peng, Shunli ;
Wang, Wei ;
Chen, Longhua .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (05) :1132-1140
[6]
miR-125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathway [J].
Tang, Hao ;
Li, Rong-Ping ;
Liang, Ping ;
Zhou, Ya-Long ;
Wang, Guang-Wei .
ONCOLOGY LETTERS, 2015, 10 (02) :681-686
[7]
Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/refractory indolent lymphoma [J].
Cheah, Chan Yoon ;
Nastoupil, Loretta J. ;
Neelapu, Sattva S. ;
Forbes, Sheryl G. ;
Oki, Yasuhiro ;
Fowler, Nathan H. .
BLOOD, 2015, 125 (21) :3357-3359
[8]
Overexpression of Cytokeratin 19; Aldolase A and Manganese Superoxide Dismutase in Ovine Pulmonary Adenocarcinoma.[J].A. Kycko;M. Reichert.Journal of Comparative Pathology.2014, 1
[9]
Signaling networks of Rho GTPases in cell motility [J].
Hanna, Samer ;
El-Sibai, Mirvat .
CELLULAR SIGNALLING, 2013, 25 (10) :1955-1961
[10]
Hallmarks of Cancer: The Next Generation [J].
Hanahan, Douglas ;
Weinberg, Robert A. .
CELL, 2011, 144 (05) :646-674